DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sotradecol (Sodium Tetradecyl Sulfate) - Published Studies

 
 



Sotradecol Related Published Studies

Well-designed clinical trials related to Sotradecol (Sodium Tetradecyl Sulfate)

Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). [2010.06]

Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). [2010]

Comparison of ethanol and sodium tetradecyl sulfate in the sclerotherapy of renal cyst. [2007.08]

Well-designed clinical trials possibly related to Sotradecol (Sodium Tetradecyl Sulfate)

Comparison of aspiration-sclerotherapy with hydrocelectomy in the management of hydrocele: a prospective randomized study. [2009.08]

Reverse foam sclerotherapy of the great saphenous vein with sapheno-femoral ligation compared to standard and invagination stripping: a prospective clinical series. [2008.10]

Other research related to Sotradecol (Sodium Tetradecyl Sulfate)

Comparison of sonographically guided percutaneous sodium tetradecyl sulfate injection with ethanol injection in the treatment of benign nonfunctioning thyroid nodules. [2014]

Deactivation of sodium tetradecyl sulphate injection by blood proteins. [2011.04]

Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. [2011.03]

Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases. [2011.02]

Extensive muscle necrosis and infection following treatment of a lower extremity vascular malformation with Sotradecol and absolute ethanol. [2010.07]

The first case of takotsubo cardiomyopathy associated with sodium tetradecyl sulphate sclerotherapy. [2010.04]

Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations. [2010.03]

The impact of different concentrations of sodium tetradecyl sulphate and initial balloon denudation on endothelial cell loss and tunica media injury in a model of foam sclerotherapy. [2010.03]

Histological and biomechanical effects of palatal sclerotherapy in the horse using sodium tetradecyl sulfate. [2010.03]

Chronic facial pain following injection of sodium tetradecyl sulphate into an intraparotid haemolymphangioma. [2008.09]

Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate. [2008.07]

Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam. [2008.07]

Initial experience with 3% sodium tetradecyl sulfate foam and fibered coils for management of adolescent varicocele. [2008.02]

Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate--outcome in 244 patients. [2008.02]

Anaphylactoid reaction after the use of sodium tetradecyl sulfate: a case report. [2007.10]

FDA-approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy. [2007.09]

Use of intraoperative sodium tetradecyl sulfate for the treatment of a spinal epidural hemangioma. Technical note. [2007.08]

Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. [2007.03]

Other possibly related research studies

Percutaneous treatment of lymphatic malformations. [2009.08]

Aesthetic treatment of leg veins. [2008.09]

Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins. [2009.01]

Primary venous aneurysms of the superficial venous system. [2008.10]

Palatal sclerotherapy: a potentially useful treatment of intermittent dorsal displacement of the soft palate in juvenile standardbred racehorses. [2008.06]

Single dose injection snoreplasty: investigation or treatment? [2008.11]

The effect of endovenous laser ablation on restless legs syndrome. [2008]

Retrograde percutaneous sclerotherapy of left idiopathic varicocele in children: results and follow-up. [2008.05]

Vallecular varix causing diagnostic confusion in hematemesis. [2008.12]

Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. [2008.01]

Immediate pathologic effects on the vein wall of foam sclerotherapy. [2007.10]

Endoscopic abnormalities in the oesophagus after variceal sclerotherapy--a long-term follow up study. [2007.01]

Feasibility study of inhaled hepatitis B vaccine formulated with tetradecylmaltoside. [2008.03]

Foam sclerotherapy with Fibrovein (STD) for the treatment of hemorrhoids, using a flexible endoscope. [2007.08]

Efficacy of local sclerosing agents on hemostasis of hepatic bleeding. [2007.06]

Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation. [2007.07]

The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland. [2007.08]

Management of oral lesions in HIV-positive patients. [2007.03]

Profuse bleeding in patients with chronic venous insufficiency. [2007.03]

[Injection sclerotherapy for varicosities of the lower limb: 25 years of experience with 115000 injections] [2007.01.14]

Cyanoacrylate glue in the management of gastric varices. [2009.02]

Sclerosants: a comparative review. [2010.06]

Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. [2009.04]

Complications and side-effects of foam sclerotherapy. [2009.12]

Intravascular papillary endothelial hyperplasia of the lower lip: surgical approach and review of the literature. [2009.12]

Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy. [2009]

Technique and early results of ultrasound-guided foam sclerotherapy of the long saphenous vein for treatment of varicose veins. [2009.03]

Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. [2011.07.29]

Air versus physiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins. [2011.07]

Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. [2011.07]

Treatment of a branchial sinus tract by sclerotherapy. [2011.02]

An investigation into the influence of various gases and concentrations of sclerosants on foam stability. [2011.01]

New technique to heal venous ulcers: terminal interruption of the reflux source (TIRS). [2010.09]

Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications. [2011.06]

Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic primary great saphenous varicose veins. [2010.10]

Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures. [2009.08]

An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study. [2011.09.16]

Sclerotherapy for lower limb telangiectasias. [2011]

An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study. [2012]

Interim results on abolishing reflux alongside a randomized clinical trial on laser ablation with phlebectomies versus foam sclerotherapy. [2013]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017